Learn More
BACKGROUND/AIMS Alzheimer's disease (AD) is a well-known type of dementia. However, it remains difficult to identify AD in the early stage and to distinguish it from other dementing disorders. We examined glycoproteins in cerebrospinal fluid (CSF) as potential biological markers of AD. METHODS CSF samples were collected from AD, other dementia and(More)
  • 1